Tepper CG - Search Results

1

Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.

Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. Pan CX, et al. Among authors: tepper cg. PLoS One. 2015 Aug 13;10(8):e0134346. doi: 10.1371/journal.pone.0134346. eCollection 2015. PLoS One. 2015. PMID: 26270481 Free PMC article. Clinical Trial.

2

Molecular alterations associated with LNCaP cell progression to androgen independence.

Shi XB, Ma AH, Tepper CG, Xia L, Gregg JP, Gandour-Edwards R, Mack PC, Kung HJ, deVere White RW. Shi XB, et al. Among authors: tepper cg. Prostate. 2004 Aug 1;60(3):257-71. doi: 10.1002/pros.20039. Prostate. 2004. PMID: 15176055

3

Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.

Tepper CG, Gregg JP, Shi XB, Vinall RL, Baron CA, Ryan PE, Desprez PY, Kung HJ, deVere White RW. Tepper CG, et al. Prostate. 2005 Dec 1;65(4):375-89. doi: 10.1002/pros.20308. Prostate. 2005. PMID: 16037992

4

Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.

You Z, Shi XB, DuRaine G, Haudenschild D, Tepper CG, Lo SH, Gandour-Edwards R, de Vere White RW, Reddi AH. You Z, et al. Among authors: tepper cg. Cancer Res. 2006 Jan 1;66(1):175-83. doi: 10.1158/0008-5472.CAN-05-1130. Cancer Res. 2006. PMID: 16397230

5

The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7.

Vinall RL, Tepper CG, Shi XB, Xue LA, Gandour-Edwards R, de Vere White RW. Vinall RL, et al. Among authors: tepper cg. Oncogene. 2006 Mar 30;25(14):2082-93. doi: 10.1038/sj.onc.1209246. Oncogene. 2006. PMID: 16434975

6

Genomic and functional profiling of duplicated chromosome 15 cell lines reveal regulatory alterations in UBE3A-associated ubiquitin-proteasome pathway processes.

Baron CA, Tepper CG, Liu SY, Davis RR, Wang NJ, Schanen NC, Gregg JP. Baron CA, et al. Among authors: tepper cg. Hum Mol Genet. 2006 Mar 15;15(6):853-69. doi: 10.1093/hmg/ddl004. Epub 2006 Jan 30. Hum Mol Genet. 2006. PMID: 16446308

7

ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.

Zou JX, Zhong Z, Shi XB, Tepper CG, deVere White RW, Kung HJ, Chen H. Zou JX, et al. Among authors: tepper cg. Prostate. 2006 Oct 1;66(14):1474-86. doi: 10.1002/pros.20477. Prostate. 2006. PMID: 16921507

8

Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.

Ma AH, Xia L, Desai SJ, Boucher DL, Guan Y, Shih HM, Shi XB, deVere White RW, Chen HW, Tepper CG, Kung HJ. Ma AH, et al. Among authors: tepper cg. Cancer Res. 2006 Sep 1;66(17):8439-47. doi: 10.1158/0008-5472.CAN-06-1636. Cancer Res. 2006. PMID: 16951154

9

GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.

Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. Tepper CG, et al. Prostate. 2007 Apr 1;67(5):521-35. doi: 10.1002/pros.20548. Prostate. 2007. PMID: 17252539

10

The oncogenic potential of a prostate cancer-derived androgen receptor mutant.

Shi XB, Xue L, Tepper CG, Gandour-Edwards R, Ghosh P, Kung HJ, DeVere White RW. Shi XB, et al. Among authors: tepper cg. Prostate. 2007 May 1;67(6):591-602. doi: 10.1002/pros.20544. Prostate. 2007. PMID: 17262801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters